HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
Philip J. Palumbo(Johns Hopkins University), Susan H. Eshleman(Johns Hopkins University), Maria A. Papathanasopoulos(University of the Witwatersrand), Jessica M. Fogel(Johns Hopkins University), Breno Santos(Hospital Nossa Senhora da Conceição), Shanmugam Saravanan(YR Gaitonde Centre for AIDS Research and Education), Laura Hovind(Frontier Science & Technology Research Foundation, Inc.), Myron S. Cohen(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Sharlaa Badal‐Faesen(University of the Witwatersrand), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Victor Akelo(Centers for Disease Control and Prevention), James Hakim(University of Zimbabwe), Srikanth Tripathy(Indian Council of Medical Research), Marybeth McCauley(Family Health International 360), Joel E. Gallant(Johns Hopkins University), Ravindre Panchia(Chris Hani Baragwanath Hospital), Ethan Wilson(Fred Hutch Cancer Center), Theresa Gamble(University of Utah), Mariza Gonçalves Morgado(Fundação Oswaldo Cruz), José Henrique Pilotto(Universidade Iguaçu), Stephen A. Hart(Nationwide Children's Hospital), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheela Godbole(The Ohio State University Wexner Medical Center), Carole L. Wallis, Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Sarah E. Hudelson(Johns Hopkins University), Joseph Makhema(University of Namur), Mina C. Hosseinipour
Cited by 15
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k